The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.
Open accessAbstract
OBJECTIVES: The contribution of bacterial coinfection to critical illness associated with 2009 influenza A virus infection remains uncertain. The objective of this study was to determine whether bacterial coinfection increased the morbidity and mortality of 2009 influenza A. DESIGN: Retrospective and prospective cohort study. SETTING: Thirty-five adult U.S. intensive care units over the course of 1 yr. PATIENTS: Six hundred eighty-three critically ill adults with confirmed or probable 2009 influenza A. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A confirmed or probable case was defined as a positive 2009 influenza A test result or positive test for influenza A that was otherwise not subtyped. Bacterial coinfection was defined as documented bacteremia or any presumed bacterial pneumonia with or without positive respiratory tract culture within 72 hrs of intensive care unit admission. The mean age was 45±16 yrs, mean body mass index was 32.5±11.1 kg/m, and mean Acute Physiology and Chronic Health Examination II score was 21±9, with 76% having at least one comorbidity. Of 207 (30.3%) patients with bacterial coinfection on intensive care unit admission, 154 had positive cultures with Staphylococcus aureus (n=57) and Streptococcus pneumoniae (n=19), the most commonly identified pathogens. Bacterial coinfected patients were more likely to present with shock (21% vs. 10%; p=.0001), require mechanical ventilation at the time of intensive care unit admission (63% vs. 52%; p=.005), and have longer duration of intensive care unit care (median, 7 vs. 6 days; p=.05). Hospital mortality was 23%; 31% in bacterial coinfected patients and 21% in patients without coinfection (p=.002). Immunosuppression (relative risk 1.57; 95% confidence interval 1.20 -2.06; p=.0009) and Staphylococcus aureus at admission (relative risk 2.82; 95% confidence interval 1.76-4.51; p<.0001) were independently associated with increased mortality. CONCLUSIONS: Among intensive care unit patients with 2009 influenza A, bacterial coinfection diagnosed within 72 hrs of admission, especially with Staphylococcus aureus, was associated with significantly higher morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunosuppression is associated with more severe morbidity and a much higher risk of mortality from co/secondary bacterial infection (Rice et al., 2012).”
From Secondary bacterial infections associated with influenza pandemics (2017) · cites this paper as Rice et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,920
Liu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,260
Incidence and Outcomes of Acute Lung Injury
Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., & Hudson, L. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050333 · Cited by 3,684
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Self-citationLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Briel, M., Meade, M., Mercat, A., Brower, R. G., Talmor, D., Walter, S. D., Slutsky, A. S., Pullenayegum, E., Zhou, Q., Cook, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.218 · Cited by 1,467
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Meade, M. O., Cook, D. J., Guyatt, G. H., Slutsky, A. S., Arabi, Y. M., Cooper, D. J., Davies, A. R., Hand, L. E., Zhou, Q., Thabane, L., et al. (2008) · JAMA · doi:10.1001/jama.299.6.637 · Cited by 1,370
Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C. E., Corrales, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904252 · Cited by 1,325
Research works printed but not linked: 1
- Hanslik, 2010, PLoS Curr Influenza, 9, RRN1150
Cited by
Sorted by citations
Items 201–300 of 389
Severe viral pneumonia in adults: what is important for the ICU physician?
Gattarello, S., & Rello, J. (2017) · Hospital Practice · doi:10.1080/21548331.2017.1345280 · Cited by 12
Robinson, K. M., Ramanan, K., Tobin, J. M., Nickolich, K. L., Pilewski, M. J., Kallewaard, N. L., Sellman, B. R., Cohen, T. S., & Alcorn, J. F. (2019) · JCI Insight · doi:10.1172/jci.insight.125554 · Cited by 13
Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus
Chen, Y., Huang, C., Li, S.-W., Pan, Y., Lin, T., Huang, Y.-Y., Li, T.-H., Yang, Y., Gong, Y., & Hsieh, Y. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00756-0 · Cited by 11
Moffitt, K. L., Nakamura, M. M., Young, C. C., Newhams, M. M., Halasa, N., Reed, J. N., Fitzgerald, J. C., Spinella, P. C., Soma, V. L., Walker, T. C., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad122 · Cited by 12
Self-citationEicosanoid Profile of Influenza A Virus Infected Pigs
Schultz, D., Methling, K., KoInfekt Study Group, Rothe, M., & Lalk, M. (2019) · Metabolites · doi:10.3390/metabo9070130 · Cited by 11
α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?
Hogan, G., Geoghegan, P., Carroll, T. P., Clarke, J., McElvaney, O. F., McElvaney, O. J., McElvaney, N. G., & Curley, G. F. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003727 · Cited by 11
Khalil, M. A. F., El-Ansary, M. R. M., Bassyouni, R. H., Mahmoud, E. E., Ali, I. A. E. R., Ahmed, T. I., Hassan, E. A., & Samir, T. M. (2022) · Diagnostics · doi:10.3390/diagnostics12071719 · Cited by 11
Erdem, İ., Ardic, E., Turker, E., Kardan, M. E., & Demirkapu, M. J. (2022) · Archives of Medical Science · doi:10.5114/aoms/152752 · Cited by 10
Davies, S., Boller, E., Chase, J. G., Beaubrun, A. C., Miller, C., & Jensen, I. S. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2313391 · Cited by 10
Influenza A virus and related secondary bacterial infections
Sheykhsaran, E., Hemmat, N., & Baghi, H. B. (2018) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000164 · Cited by 9
Fernandes, C. A., da Cunha, A. M., Hemkemaier, E. C. R. C., do Carmo, K. D. S., Moraes, T. V. P., dos Santos, T. P., da Silva, J. F. Á., de Melo, L. E. P. B., & Mateus, N. C. (2020) · Health Residencies Journal - HRJ · doi:10.51723/hrj.v1i1.20 · Cited by 10
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection
Chivukula, R. R., Maley, J. H., Dudzinski, D. M., Hibbert, K. A., & Hardin, C. C. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620969132 · Cited by 10
Lin, C., Chang, C., Yeh, C., Chang, Y., Chen, T.-L., & Liao, C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109930 · Cited by 10
Polymicrobial Infections in the Immunocompromised Host: The COVID-19 Realm and Beyond
Higgins, E., Gupta, A., & Cummins, N. W. (2022) · Medical Sciences · doi:10.3390/medsci10040060 · Cited by 10
Antiviral epithelial-macrophage crosstalk permits secondary bacterial infections
Lane, S., White, T. L. A., Walsh, E., Cattley, R. T., Cumberland, R. L., Hawse, W. F., Delgoffe, G. M., Badylak, S. F., & Bomberger, J. M. (2023) · mBio · doi:10.1128/mbio.00863-23 · Cited by 10
Raghavan, S., & Kim, K.-S. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107308 · Cited by 10
Etiology and characteristics of community-acquired pneumonia in an influenza epidemic period
Lin, C., Chen, H., He, P., Li, Y., Ke, C., & Jiao, X. (2019) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2019.03.004 · Cited by 9
Bergmann, F., Gabler, C., Nussbaumer-Pröll, A. K., Wölfl‐Duchek, M., Blaschke, A., Radtke, C., Zeitlinger, M. A., & Jorda, A. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000895 · Cited by 10
Antibiotics Used for COVID-19 In-Patients from an Infectious Disease Ward
Sturza, F., Guță, Ș.-D., & Popescu, G.-A. (2023) · Antibiotics · doi:10.3390/antibiotics12010150 · Cited by 9
Murphy, D. J., Rubinson, L., Blum, J. M., Isakov, A., Bhagwanjee, S., Cairns, C. B., Cobb, J. P., & Sevransky, J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001274 · Cited by 9
Self-citationSharma, Y., Horwood, C., Chua, A. C. L., Hakendorf, P. H., & Thompson, C. H. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100682 · Cited by 9
Sarton, B., Grare, M., Bounes, F. V., Gaubert, A., Silva, S., Crognier, L., Riu, B., Seguin, T., Georges, B., Minville, V., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10081952 · Cited by 9
Delhommeau, G., Buetti, N., Neuville, M., Siami, S., Cohen, Y., Laurent, V., Mourvillier, B., Reignier, J., Goldgran-Tolédano, D., Schwebel, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102646 · Cited by 9
Contribution of bacterial coinfection to severe influenza infection*
Chertow, D. S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182451fd8 · Cited by 9
Yang, W., Bai, X., Li, H., Li, H., Fan, W.-H., Zhang, H., Liu, W., & Sun, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.841462 · Cited by 8
Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients
Raymond, M., Martin, M., Lamouche-Wilquin, P., Blonz, G., Decamps, P., Agbakou, M., Desmedt, L., Reignier, J., Lascarrou, J.-B., & Canet, E. (2022) · Medicine · doi:10.1097/md.0000000000032245 · Cited by 8
Shirata, M., Ito, I., Jo, T., Iwao, T., Oi, I., Hamao, N., Nishioka, K., Yamana, H., Nagase, T., Yasunaga, H., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad222 · Cited by 10
Schoettler, J. J., Sandrio, S., Boesing, C., Bauer, L., Miethke, T., Thiel, M., & Krebs, J. (2023) · Pathogens · doi:10.3390/pathogens12070927 · Cited by 10
Siqueira, B. A., Bredariol, K. O., Boschiero, M. N., & Marson, F. A. L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1462802 · Cited by 8
Legionnaire's Disease and Influenza
Magira, E. E., & Zakynthinos, S. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.10.010 · Cited by 8
Wang, X., Lu, Y., Sun, C., Zhong, H., Cai, Y., Cao, M., Cui, X., Sun, W., Wang, L., Lu, X., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00607-25 · Cited by 7
Antos, D., Parks, O. B., Duray, A. M., Abraham, N., Michel, J. J., Kupul, S., Westcott, R., & Alcorn, J. F. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012498 · Cited by 7
Alshammari, A. K., Maina, M., Blanchard, A. M., Daly, J. M., & Dunham, S. P. (2025) · Pathogens · doi:10.3390/pathogens14020114 · Cited by 7
Streptococcus pneumoniae Coinfection in COVID-19 in the Intensive Care Unit: A Series of Four Cases
Shah, S. B., Karlapalem, C., Patel, P., & Madan, N. (2022) · Case Reports in Critical Care · doi:10.1155/2022/8144942 · Cited by 8
Saura, O., Chommeloux, J., Levy, D. E., Assouline, B., Lefèvre, L., & Luyt, C. E. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2134116 · Cited by 7
Humoral and cellular immune responses in critically ill influenza A/H1N1‐infected patients
Paramsothy, A., Lartey, S. L., Davies, R., Guttormsen, A. B., Cox, R. J., & Mohn, K. G.-I. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13045 · Cited by 7
Nosocomial infections amongst critically ill COVID-19 patients in Australia
Ramanan, M., Burrell, A. J. C., Paul, E. M., Trapani, T. V., Broadley, T., McGloughlin, S., French, C., & Udy, A. A. (2021) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2021.100054 · Cited by 7
Martín‐Loeches, I., & Vallés, J. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2677-y · Cited by 7
Treating influenza with antibiotics
Levet, P., Raoult, D., & Parola, P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.012 · Cited by 7
Bayındır, M., & Bayindir, E. E. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3648292 · Cited by 7
Hong, T. H., Lee, H., Kim, N.-E., Lee, K. J., Kim, Y. K., An, J. N., Kim, J., Kim, H. W., & Park, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164911 · Cited by 6
Wang, S., Yang, J., Sun, W., & Tao, Y. (2024) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-024-00715-1 · Cited by 6
Management of Severe Influenza
O’Driscoll, L. S., & Martín‐Loeches, I. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1735491 · Cited by 6
The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
Driedger, M., Daneman, N., Brown, K. A., Gold, W. L., Jorgensen, S. C. J., Maxwell, C. J., Schwartz, K. L., Morris, A. M., Thiruchelvam, D., Langford, B. J., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02630-23 · Cited by 6
Potential for Bacteriophage Therapy for Staphylococcus Aureus Pneumonia with Influenza a Coinfection
Speck, P. G., Warner, M. S., Bihari, S., Bersten, A. D., Mitchell, J. G., Tucci, J., & Gordon, D. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0163 · Cited by 6
Co-infection in severe influenza: a new epidemiology?
Luyt, C. E., & Rice, T. W. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4597-8 · Cited by 6
Self-citationSoultan, K. M., Kewalramani, A., Bradbury, A., Wang, Y., Abdallah, M., Episcopia, B., & Quale, J. M. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108072 · Cited by 5
Martín‐Loeches, I., & Restrepo, M. I. (2024) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001192 · Cited by 5
Pöhlmann, J., Joecker, A., Wittki, T., Brown, T., Pollock, R. F., & Chase, J. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03156-0 · Cited by 5
Gomi, S., Price, E., Burgoyne, H. M., Faozia, S., Katahira, E. J., McIndoo, E. R., Nmaju, A. A., Sharma, K., Aghazadeh‐Habashi, A., Bryant, A. E., et al. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00469-25 · Cited by 5
Rolfes, M. A. R., Gross, F. L., Flannery, B. L., Meyers, A. F. A., Luo, M., Bastien, N., Fowler, R., Katz, J. M., Levine, M. Z., Kumar, A., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy013 · Cited by 5
Self-citationMoore, S. (2020) · The University of Louisville Journal of Respiratory Infections · doi:10.18297/jri/vol4/iss1/15 · Cited by 5
Respiratory Mechanics in a Cohort of Critically Ill Subjects With COVID-19 Infection
Longino, A. A., Riveros, T., Risa, E. L., Hebert, C., Krieger, J. A., Coppess, S. M., McGuire, F., Bhatraju, P. K., Town, J. A., & Johnson, N. J. (2021) · Respiratory Care · doi:10.4187/respcare.09064 · Cited by 5
Potential environmental and health risk when returning to normal amidst COVID-19 vaccination
Lancaster, E., & Lee, J. (2022) · Current Opinion in Environmental Science & Health · doi:10.1016/j.coesh.2022.100328 · Cited by 6
Type I IFN Exhaustion is a Host Defence Protecting Against Secondary Bacterial Infections
Furuya, Y., & Müllbacher, A. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12107 · Cited by 5
Vandroux, D., Kerambrun, H., Ferdynus, C., Allou, N., Allyn, J., Gaüzère, B.-A., Martinet, O., & Jabot, J. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.12.043 · Cited by 5
Бородулина, Е. А., Shirobokov, Y. E., Гладунова, Е. П., & Kudlay, D. A. (2020) · Clinical pharmacology and therapy · doi:10.32756/0869-5490-2020-3-61-66 · Cited by 5
Takayama, Y., Yano, H., Nojima, Y., Nakano, R., Okamoto, R., Hirakata, Y., Sunakawa, K., Akahoshi, T., & Kaku, M. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.07.012 · Cited by 5
Neumann, G., Cowling, B. J., Chen, H., Stertz, S., Manicassamy, B., Barr, I., Uyeki, T. M., & Kawaoka, Y. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00727-5 · Cited by 5
Self-citationMortality Associated with Infectious Diseases in Dutch Nursing Homes
Manyam, M., Biesheuvel, M., Haenen, A. P. J., van Werkhoven, C. H., van de Kassteele, J., van Gageldonk-Lafeber, R., de Greeff, S. C., van Asten, L., van Houten, P., van den Bos, M., et al. (2024) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2024.105198 · Cited by 4
COVID-19 and Influenza: Differences, Similarities, and Coinfection
Shirvani, F., Babaie, D., & Karimi, A. M. (2022) · Archives of Pediatric Infectious Diseases · doi:10.5812/pedinfect.114358 · Cited by 4
Britto, C., Mohorianu, I. I., Yeung, T., Cheung, E., Novak, T., Hall, M. W., Mourani, P. M., Weiss, S. L., Thomas, N. J., Markovitz, B. P., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac325 · Cited by 4
Self-citationДмитриевич, М. С., Oe, O., Yankovskaya, O. S., Gosteva, I. V., Galitskiy, A. A., Karpova, I. V., Vedyashkina, S. G., & Shkoda, A. S. (2022) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2022.2.181-192 · Cited by 4
Said, K. B., ALGhasab, N. S., Alharbi, M. S., Alsolami, A. A., Saleem, M., Alhallabi, S. A., Alafnan, S. F., Khaja, A. S. S., & Taha, T. E. (2023) · Microorganisms · doi:10.3390/microorganisms11010149 · Cited by 5
Xu, C., Wang, Z., Yu, B., Pan, Z., Ni, J., Feng, Y., Huang, S., Wu, M., Zhou, J., Fang, L., et al. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199410 · Cited by 4
Highly dampened blood transcriptome response in HIV patients after respiratory infection
Sellers, S. A., Fischer, W. A., Heise, M. T., & Schughart, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-83876-9 · Cited by 4
Valsecchi, P., Colaneri, M., Zuccaro, V., Asperges, E., Costanzo, F., Mariani, B., Roda, S., Minucci, R., Bertuccio, F. R., Fraolini, E., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080762 · Cited by 4
Novel Requirement for Staphylococcal Cell Wall-Anchored Protein SasD in Pulmonary Infection
Grousd, J. A., Dresden, B. P., Riesmeyer, A. M., Cooper, V. S., Bomberger, J. M., Richardson, A. R., & Alcorn, J. F. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01645-22 · Cited by 4
Laethem, J. V., Pierreux, J., Wuyts, S. C. M., Geyter, D. D., Allard, S. D., & Dauby, N. (2023) · Acta Clinica Belgica · doi:10.1080/17843286.2023.2167328 · Cited by 4
Paul, V., Varshney, A. K., Nandru, R., Kushwaha, S., Prasad, V., & Dasgupta, S. (2023) · Journal of Medicinal Plants Studies · doi:10.22271/plants.2023.v11.i1a.1506 · Cited by 4
Are Mycoplasma pneumoniae coinfections frequent in COVID-19 patients? A systematic review
Mosmann, J., Frutos, M. C., Origlia, J. A., Vaulet, M. L. G., García, M. G., Vilar, G., Pérez, C., Madariaga, M. J., Cuffini, C., & Cadario, M. E. (2024) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2024.05.002 · Cited by 3
Risk factors for re-hospitalization within 90 days of discharge for severe influenza in children
Yang, S., Lu, S., Qi, C., Guo, Y., & Wang, L. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10492-7 · Cited by 3
Menis, A. A., Gerovasileiou, E. S., Mantzarlis, K. D., Manoulakas, E., Deskata, K., Vazgiourakis, V., Makris, D. A., & Dimοpoulos, G. (2025) · Viruses · doi:10.3390/v17060851 · Cited by 5
Brown, M., Abeer, F., Roe, T., Beecham, R., Arscott, O., Eastwood, B., Mahar, S., Montague, M., Neseam, D., Patel, P., et al. (2025) · Infection · doi:10.1007/s15010-025-02637-2 · Cited by 5
Chen, W., Kao, K., Sheu, C., Chan, M.-C., Chen, Y., Chien, Y., Peng, C., Liang, S., Hu, H., Tsai, M., et al. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620942417 · Cited by 3
Shiralizadeh, S., Azimzadeh, M., Keramat, F., Hashemi, S. H., Majzoobi, M. M., Arabestani, M. R., Jalilian, F. A., Taher, A., Khazaei, S., Alikhani, M. S., et al. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265338445241007092436 · Cited by 3
Protective mechanical ventilation in suspected influenza infection
Pimenta, L. B. M., Sanson, N. Z., Volpe, M. S., Amato, M. B. P., Micheletti, A. M. R., & Teixeira, L. D. A. S. (2020) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0481-2019 · Cited by 3
NLRP6 Induces Lung Injury and Inflammation Early in Brucella and Influenza Coinfection
Shi, B., Han, H., Li, H., Tan, L., Li, X., Wang, K., Li, B., He, W., Tian, C., Fang, Y., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12122063 · Cited by 3
Attal, R., & Deotale, V. S. (2024) · PubMed Central · doi:10.3205/dgkh000465 · Cited by 3
Almulhim, A., Alabdulwahed, M. A., Al-Doughan, F., Aldayyen, A. M., Alghamdi, F., Alabdulqader, R., Alnaim, N. M., Alghannam, D., Aljamaan, Y., Almutairi, S., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17050624 · Cited by 3
Karakoç, H. N., Aydın, M., Ozcan, S. N., Olçar, Y., Şumlu, E., Dindar, E. K., Arslan, Y. K., & Sajadi, M. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-72086-8 · Cited by 3
Wendel‐Garcia, P. D., Ceccato, A., Motos, A., Franch-Llasat, D., Pérez-Moreno, M. O., Domenech-Spanedda, M. F., Chamarro-Martí, E., Ferrer, R., Fernández‐Barat, L., Riera, J., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106411 · Cited by 3
COVID-19 with Multiple Bacterial Co-infections: A Case Report
Saber, S., Ahmed, S. R., Yasmin, N., Alam, M. T., Momen, A., Hossain, M. M., & Alam, R. F. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.646 · Cited by 3
Clinical and radiological variants of lung damage in the infection caused by staphylococcus aureus
Сергеевич, В. А., Smirnova, A. D., Belenkaya, O. I., Yudin, A., & Yumatova, E. A. (2021) · Journal of clinical practice · doi:10.17816/clinpract71642 · Cited by 3
Jansen, D., van den Berg, R., & Bosman, G. J. C. G. M. (2014) · Cited by 3
Comparison Of Moderate And Severe Hospitalized Pediatric 2009 H1N1 Influenza Cases
LaBeaud, A. D., Wentworth, B. A., Gildengorin, G. L., Tam, K., Guardia-LaBar, L. M., & Petru, A. M. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31827882f9 · Cited by 3
Estapé, J. V., Zboromyrska, Y., Vergara, A., Alejo-Cancho, I., Rubio-García, E., Álvarez-Martínez, M. J., Brugada, J. P. D. L. B., & Maeso, M. Á. M. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(16)30218-x · Cited by 3
Risk stratification for selecting empiric antibiotherapy during and after COVID-19
Zahar, J., & Timsit, J. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000881 · Cited by 3
Latha, K., Rao, S., Sakamoto, K., & Watford, W. T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01136-22 · Cited by 2
Shmoury, A. H., Zakhour, J., Sawma, T., Haddad, S. F., Zahreddine, N. K., Tannous, J., Fakhreddine, H. B., Rizk, N., & Kanj, S. S. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.10.026 · Cited by 2
Interleukin-35 mRNA therapy for influenza virus-induced pneumonia in mice
Li, Y., Liao, Y., Miao, Y., Yu, C., Long, J., Wu, J., Zuo, J., Zhang, Z., Dou, W., Wang, X., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177366 · Cited by 2
Fang, L., Li, C., Ding, H., & Tao, J. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100807 · Cited by 2
Peng, K.-C., Li, Q., Chen, L., Zhao, Y. G., Liu, H., Kong, Z., & Luo, Z. (2025) · Children · doi:10.3390/children12091146 · Cited by 2
Li, W., Di, X., Lv, X., Zhang, L., & Yu, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662422 · Cited by 2
Current insights into bacterial secondary infection following influenza A virus infection
Seo, J.-H., Seo, Y.-J., Ryu, H., Shin, M., & Lee, C.-Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1851115 · Cited by 2
Proaños, N. J., Reyes, L. F., Bastidas, A., Martín‐Loeches, I., Dı́az, E., Suberviola, B., Moreno, A. A., Bodí, M. A., Nieto, M., Estella, Á., et al. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2021.05.009 · Cited by 2
Stolfa, S., Romanelli, F., Ronga, L., Raffaele, D. P., & Mosca, A. (2021) · Pharmacophore · doi:10.51847/6fnkoyvism · Cited by 2
The Frequency and the character of bacterial infection in patients with COVID-19
Кароли, Н. А., & Rebrov, A. P. (2023) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2023-4-1-28-39 · Cited by 2
Moore, S. E., Hebert, B., & Wilde, A. M. (2024) · Norton Healthcare Medical Journal · doi:10.59541/001c.118568 · Cited by 2
Chen, L., & Weng, H. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03162-y · Cited by 2
Metadata
- Authors
- Rice, T. W., Rubinson, L., Uyeki, T. M., Vaughn, F. L., John, B. B., Miller, R. R., Higgs, E., Randolph, A. G., Smoot, B. E., & Thompson, B. T.
- Affiliations
- Vanderbilt University (US)
- Centers for Disease Control and Prevention (US)
- University of Utah (US)
- National Institutes of Health (US)
- Boston Children's Hospital (US)
- Harvard University (US)
- Venue
- Critical Care Medicine
- Published
- 2012-05
- Volume
- 40
- Issue
- 5
- Pages
- 1487-1498
- ISSN
- 0090-3493 (ISSN-L)
- PMC
- PMC3653183
- OpenAlex
- W1995615618
- Cited by
- 391
- References
- 37
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 30 · 2023: 30 · 2022: 51 · 2021: 60 · 2020: 48 · 2019: 20 · 2018: 21 · 2017: 20 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 24 · 2012: 7
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01hr56174-20-0-1, n01hr56179-17-0-1)
- National Heart, Lung, and Blood Institute (N01 HR 56179, K23HL081431, N01 HR056179, N01 HR056174)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- bacterial co-infection, critical illness, ICU mortality, Staphylococcus aureus, Streptococcus pneumoniae, bacteremia, bacterial pneumonia, shock, mechanical ventilation, comorbidities, ICU length of stay, mortality risk factors, hospitalized adults
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacterial Infections, Female, Humans, Influenza, Human, Intensive Care Units, Male, Middle Aged, Prospective Studies, Retrospective Studies, United States, Chi-Square Distribution, Critical Illness, Statistics, Nonparametric, Influenza A Virus, H1N1 Subtype, Young Adult, Pandemics, Coinfection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review